Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC) | ANNALS OF ONCOLOGY |